The transaction is part of a broader agreement with Bureau Veritas covering its worldwide food laboratory testing activities
Akums Drugs will undertake this development and commercialization in India
eGenesis is pioneering a genome engineering-based approach in the development of safe and effective transplantable organs to end the global organ shortage
Biocon Biologics earlier announced a settlement agreement in the United States for a Bmab 1200 launch no later than February 22, 2025
Pegfilgrastim is a Pegylated form of the recombinant human granulocyte colony-stimulating factor (G-CSF) analogue Filgrastim
The transaction aligns with Lupin's strategy to grow its global presence in Specialty areas
The first and only oral androgen deprivation therapy treatment for men with advanced prostate cancer
This agreement paves the way for the introduction of YESAFILI into the Canadian market
The brands Aarne in Germany and Nalcrom in Canada and the Netherlands are being acquired
Orgovyx is the first and only oral GnRH receptor antagonist approved for advanced prostate cancer in Canada
Subscribe To Our Newsletter & Stay Updated
